JP Morgan Chase
INBX

JP Morgan Chase’s Inhibrx, Inc. Common Stock INBX Stock Holding History

JP Morgan Chase’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-72,764
Closed -$2.54M – 7917
2024
Q1 		$2.54M Buy
72,764
+21,238
+41% +$775K ﹤0.01% 3652
2023
Q4 		$1.96M Sell
51,526
-318,459
-86% -$6.82M ﹤0.01% 3854
2023
Q3 		$6.79M Buy
369,985
+3,088
+0.8% +$64.6K ﹤0.01% 2601
2023
Q2 		$9.52M Buy
366,897
+326,919
+818% +$7.63M ﹤0.01% 2324
2023
Q1 		$754K Buy
39,978
+7,707
+24% +$179K ﹤0.01% 4236
2022
Q4 		$795K Buy
32,271
+3,448
+12% +$101K ﹤0.01% 4210
2022
Q3 		$517K Buy
28,823
+3,488
+14% +$62.9K ﹤0.01% 4445
2022
Q2 		$288K Buy
25,335
+1,721
+7% +$25.3K ﹤0.01% 4884
2022
Q1 		$527K Sell
23,614
-37,702
-61% -$962K ﹤0.01% 4670
2021
Q4 		$2.68M Buy
61,316
+36,905
+151% +$1.48M ﹤0.01% 3615
2021
Q3 		$813K Sell
24,411
-5,370
-18% -$163K ﹤0.01% 4451
2021
Q2 		$820K Buy
29,781
+11,084
+59% +$231K ﹤0.01% 4416
2021
Q1 		$375K Sell
18,697
-3,787
-17% -$111K ﹤0.01% 4852
2020
Q4 		$742K Buy
+22,484
New +$598K ﹤0.01% 4135

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase's INBX Position: Q2 2024 in Review

JP Morgan Chase sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 72,764 shares — an estimated $2.54M sold.

JP Morgan Chase first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $9.52M in Q2 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • JP Morgan Chase reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 72,764 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.54M.
  • JP Morgan Chase first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • JP Morgan Chase's Inhibrx, Inc. Common Stock position peaked at $9.52M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.